Author
Listed:
- Xiaohui Zhu
(Southern Medical University
Guangdong Province Key Laboratory of Molecular Tumor Pathology)
- Xiaoming Li
(Shenzhen Bao’an People’s Hospital (group))
- Kokhaur Ong
(A*STAR
A*STAR)
- Wenli Zhang
(Southern Medical University
Guangdong Province Key Laboratory of Molecular Tumor Pathology)
- Wencai Li
(The First Affiliated Hospital of Zhengzhou University)
- Longjie Li
(A*STAR)
- David Young
(A*STAR)
- Yongjian Su
(Guangzhou F.Q.PATHOTECH Co., Ltd)
- Bin Shang
(Guangzhou F.Q.PATHOTECH Co., Ltd)
- Linggan Peng
(Guangzhou F.Q.PATHOTECH Co., Ltd)
- Wei Xiong
(Guangzhou Kaipu Biotechnology Co., Ltd)
- Yunke Liu
(Guangzhou Tianhe District Maternal and Child Health Care Hospital)
- Wenting Liao
(Sun Yat-sen University Cancer Center)
- Jingjing Xu
(The First Affiliated Hospital of Zhengzhou University)
- Feifei Wang
(Southern Medical University
Guangdong Province Key Laboratory of Molecular Tumor Pathology)
- Qing Liao
(Southern Medical University
Guangdong Province Key Laboratory of Molecular Tumor Pathology)
- Shengnan Li
(Guangzhou F.Q.PATHOTECH Co., Ltd)
- Minmin Liao
(Southern Medical University
Guangdong Province Key Laboratory of Molecular Tumor Pathology)
- Yu Li
(Southern Medical University
Guangdong Province Key Laboratory of Molecular Tumor Pathology)
- Linshang Rao
(Guangzhou F.Q.PATHOTECH Co., Ltd)
- Jinquan Lin
(Guangzhou F.Q.PATHOTECH Co., Ltd)
- Jianyuan Shi
(Guangzhou F.Q.PATHOTECH Co., Ltd)
- Zejun You
(Guangzhou F.Q.PATHOTECH Co., Ltd)
- Wenlong Zhong
(Guangzhou Huayin medical inspection center Co., Ltd)
- Xinrong Liang
(Guangzhou Huayin medical inspection center Co., Ltd)
- Hao Han
(A*STAR)
- Yan Zhang
(Southern Medical University
Shenzhen Longhua District Maternity & Child Healthcare Hospital)
- Na Tang
(Shenzhen First People’s Hospital)
- Aixia Hu
(Henan Provincial People’s Hospital)
- Hongyi Gao
(Guangdong Provincial Women’s and Children’s Dispensary)
- Zhiqiang Cheng
(Shenzhen First People’s Hospital)
- Li Liang
(Southern Medical University
Guangdong Province Key Laboratory of Molecular Tumor Pathology)
- Weimiao Yu
(A*STAR
A*STAR)
- Yanqing Ding
(Southern Medical University
Guangdong Province Key Laboratory of Molecular Tumor Pathology)
Abstract
Technical advancements significantly improve earlier diagnosis of cervical cancer, but accurate diagnosis is still difficult due to various factors. We develop an artificial intelligence assistive diagnostic solution, AIATBS, to improve cervical liquid-based thin-layer cell smear diagnosis according to clinical TBS criteria. We train AIATBS with >81,000 retrospective samples. It integrates YOLOv3 for target detection, Xception and Patch-based models to boost target classification, and U-net for nucleus segmentation. We integrate XGBoost and a logical decision tree with these models to optimize the parameters given by the learning process, and we develop a complete cervical liquid-based cytology smear TBS diagnostic system which also includes a quality control solution. We validate the optimized system with >34,000 multicenter prospective samples and achieve better sensitivity compared to senior cytologists, yet retain high specificity while achieving a speed of
Suggested Citation
Xiaohui Zhu & Xiaoming Li & Kokhaur Ong & Wenli Zhang & Wencai Li & Longjie Li & David Young & Yongjian Su & Bin Shang & Linggan Peng & Wei Xiong & Yunke Liu & Wenting Liao & Jingjing Xu & Feifei Wang, 2021.
"Hybrid AI-assistive diagnostic model permits rapid TBS classification of cervical liquid-based thin-layer cell smears,"
Nature Communications, Nature, vol. 12(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23913-3
DOI: 10.1038/s41467-021-23913-3
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Jiaxin Bai & Ning Li & Hua Ye & Xu Li & Li Chen & Junbo Hu & Baochuan Pang & Xiaodong Chen & Gong Rao & Qinglei Hu & Shijie Liu & Si Sun & Cheng Li & Xiaohua Lv & Shaoqun Zeng & Jing Cai & Shenghua Ch, 2025.
"AI-assisted cervical cytology precancerous screening for high-risk population in resource-limited regions using a compact microscope,"
Nature Communications, Nature, vol. 16(1), pages 1-13, December.
- Peng Xue & Le Dang & Ling-Hua Kong & Hong-Ping Tang & Hai-Miao Xu & Hai-Yan Weng & Zhe Wang & Rong-Gan Wei & Lian Xu & Hong-Xia Li & Hai-Yan Niu & Ming-Juan Wang & Zi-Chen Ye & Zhi-Fang Li & Wen Chen , 2025.
"Deep learning enabled liquid-based cytology model for cervical precancer and cancer detection,"
Nature Communications, Nature, vol. 16(1), pages 1-10, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23913-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.